Wellthy Therapeutics is a digital therapeutics (DTx) company that inspires and enables patients to better manage chronic diseases. Our specific digital therapeutic solutions can be delivered to patients by clinicians, as a monotherapy or alongside pharmaco-therapy as a part of a combination therapy. Wellthy Therapeutics works with health care systems, insurers, pharmaceutical companies and medical device companies to improve patient and population health outcomes. Our active therapeutic areas are in Diabetes and Cardiology. Wellthy Therapeutics’ first digital therapeutic for Type II diabetes has been endorsed by the RSSDI, Asia's largest diabetes association. Our real world evidence has been showcased through 19 publications presented on global platforms.